Cancer Drug Gleevec and Heart Failure
A small study of 10 patients who took the Novartis cancer drug Gleevec/Glivec for chronic myelogenous leukemia developed severe congestive heart failure between two and 14 months after starting treatment. The benefits of Gleevec still outweigh the side effects but doctors need to keep a close eye on cancer patients who may need supplementary heart treatment. If you’re taking Gleevec, you may want to bring this study to your doctor’s attention.
Los Angeles Times, July 23, 2006
Nature Medicine, July 23, 2006
Technorati Tags: gleevec, glivec, novartis, cancer, heart failure, heart disease, disease, illness, health, heart, cardiovascular disease, cvd
Related Stories
POSTED IN: Hearty Healthcare, Hearty News, Hearty Research
0 opinions for Cancer Drug Gleevec and Heart Failure
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: